Da Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Da Zhang has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Li Xiao
Department of Endocrinology, Air Force Medical Center, Air Force Medical University
8 shared publicationsGuangxin Zhou
Department of Endocrinology, Air Force Medical Center, Air Force Medical University
6 shared publicationsJinzheng Hou
Department of Endocrinology, Air Force Medical Center, Air Force Medical University
6 shared publicationsYukun Tao
Department of Endocrinology, Air Force Medical Center, Air Force Medical University
6 shared publicationsLulu Liu
Department of Endocrinology, Air Force Medical Center, Air Force Medical University
5 shared publicationsHuijuan Zhu
Department of Endocrinology, Air Force Medical Center, Air Force Medical University
4 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1938560
Serum magnesium and major adverse cardiovascular events in patients with diabetic foot ulcers: a retrospective cohort study
Background and aims: Patients with diabetic foot ulcers (DFU) have a high cardiovascular risk. We evaluated the association of baseline total serum magnesium (Mg) with major adverse cardiovascular events (MACE) without presuming a causal or therapeutic effect. Methods: This single-center retrospective cohort included 1,176 patients with active DFU admitted from 2015 through 2022. The endpoint was the first MACE, defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. Cox models estimated hazard ratios (HRs) per 0.1 mmol/L and per standard deviation (SD) of Mg and by data-defined quartile groups. The extended model additionally adjusted for HbA1c, eGFR, albumin, log-transformed C-reactive protein, HDL-C, and LDL-C. Restricted cubic splines used four knots. Competing-risk, renal-function, complete-case, prior-cardiovascular-disease, time-specific, and propensity-score-matched analyses were performed. Results: During a median follow-up of 3.6 years, 304 MACE events occurred, including 216 cardiovascular deaths and 88 combined nonfatal myocardial infarctions or strokes. In the extended model, each 0.1 mmol/L higher Mg was associated with lower MACE hazard (HR 0.87, 95% CI 0.80–0.95; p=0.002); the HR per SD was 0.83 (95% CI 0.74–0.94; p=0.002). The spline model supported an overall (p<0.001) and nonlinear (p0.80 mmol/L) versus low (≤0.80 mmol/L) contrast was associated with lower MACE hazard (pair-stratified HR 0.60, 95% CI 0.39–0.92; p=0.020), whereas the continuous estimate was less precise (HR 0.85, 95% CI 0.71–1.01; p=0.070). Conclusions: Baseline serum Mg was independently associated with MACE risk in patients with DFU, with an exploratory nonlinear pattern. The data-derived change points are not therapeutic boundaries and require external prospective validation. These observational findings do not establish benefit from Mg supplementation.
- 11 September 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1938560
Open AccessSerum magnesium and major adverse cardiovascular events in patients with diabetic foot ulcers: a retrospective cohort study
Background and aims: Patients with diabetic foot ulcers (DFU) have a high cardiovascular risk. We evaluated the association of baseline total serum magnesium (Mg) with major adverse cardiovascular events (MACE) without presuming a causal or therapeutic effect. Methods: This single-center retrospective cohort included 1,176 patients with active DFU admitted from 2015 through 2022. The endpoint was the first MACE, defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. Cox models estimated hazard ratios (HRs) per 0.1 mmol/L and per standard deviation (SD) of Mg and by data-defined quartile groups. The extended model additionally adjusted for HbA1c, eGFR, albumin, log-transformed C-reactive protein, HDL-C, and LDL-C. Restricted cubic splines used four knots. Competing-risk, renal-function, complete-case, prior-cardiovascular-disease, time-specific, and propensity-score-matched analyses were performed. Results: During a median follow-up of 3.6 years, 304 MACE events occurred, including 216 cardiovascular deaths and 88 combined nonfatal myocardial infarctions or strokes. In the extended model, each 0.1 mmol/L higher Mg was associated with lower MACE hazard (HR 0.87, 95% CI 0.80–0.95; p=0.002); the HR per SD was 0.83 (95% CI 0.74–0.94; p=0.002). The spline model supported an overall (p<0.001) and nonlinear (p0.80 mmol/L) versus low (≤0.80 mmol/L) contrast was associated with lower MACE hazard (pair-stratified HR 0.60, 95% CI 0.39–0.92; p=0.020), whereas the continuous estimate was less precise (HR 0.85, 95% CI 0.71–1.01; p=0.070). Conclusions: Baseline serum Mg was independently associated with MACE risk in patients with DFU, with an exploratory nonlinear pattern. The data-derived change points are not therapeutic boundaries and require external prospective validation. These observational findings do not establish benefit from Mg supplementation.
- Open Access
- 10 June 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1825009
Association of prognostic nutritional index with the risk of all-cause mortality and cardiovascular events in patients with diabetes-related foot ulcers: a non-linear relationship mediated by eGFR
Background: Diabetes-related foot ulcers (DFU), a severe complication of diabetes, is strongly associated with high mortality. Although the prognostic nutritional index (PNI) has been validated for predicting clinical outcomes, its precise relationship with mortality risk in patients with DFU remains unclear. This study aimed to investigate the association between PNI and all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE) in patients with DFU, and to elucidate the underlying non-linear mechanisms. Methods: This retrospective cohort study consecutively enrolled 1,225 patients with DFU admitted to Air Force Medical Center from January 2015 to December 2022. Cox proportional hazards models were used to calculate HR with 95% CI for evaluating the association of PNI with all endpoints and Kaplan–Meier survival curves were generated. Restricted cubic spline (RCS) evaluated non-linear associations, and piecewise regression identified risk thresholds. Causal mediation analysis quantified the mediating effect of eGFR. Results: During a median follow-up of 3.6 years, 378 (30.9%) all-cause deaths, 230 (18.8%) cardiovascular deaths, and 323 (26.4%) MACEs occurred. Multivariable-adjusted Cox proportional hazards models revealed significant inverse associations between PNI and all endpoints. In the fully adjusted model, each 1-unit increase in PNI was associated with a 5% reduction in all-cause mortality risk (HR: 0.95, 95%CI: 0.94–0.97, p < 0.001), a 4% reduction in cardiovascular mortality risk (HR: 0.96, 95%CI: 0.94–0.98, p < 0.001), and a 3% reduction in MACE risk (HR: 0.97, 95%CI: 0.95–0.98, p < 0.001). Quartile analysis revealed progressively decreasing risks across Q2 to Q4 groups versus Q1 (lowest quartile) for all endpoints. Kaplan–Meier survival curves corroborated the Cox regression results. RCS analysis demonstrated significant non-linear relationships between PNI and all endpoints, with exploratory, cohort-specific thresholds identified near 39.29–39.37 (non-linear p < 0.05). Causal mediation analysis revealed that eGFR mediated 11.5 and 11.9% of the effects of PNI on the risks of all-cause mortality and cardiovascular mortality, respectively ( p < 0.05). Conclusion: Prognostic nutritional index is an independent protective factor associated with lower risks of all-cause mortality, cardiovascular mortality, and MACE in patients with DFU. Elevated PNI is associated with significantly reduced risks of all-cause mortality and cardiovascular events, with eGFR partially mediating this association.
- 10 June 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1825009
Open AccessAssociation of prognostic nutritional index with the risk of all-cause mortality and cardiovascular events in patients with diabetes-related foot ulcers: a non-linear relationship mediated by eGFR
Background: Diabetes-related foot ulcers (DFU), a severe complication of diabetes, is strongly associated with high mortality. Although the prognostic nutritional index (PNI) has been validated for predicting clinical outcomes, its precise relationship with mortality risk in patients with DFU remains unclear. This study aimed to investigate the association between PNI and all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE) in patients with DFU, and to elucidate the underlying non-linear mechanisms. Methods: This retrospective cohort study consecutively enrolled 1,225 patients with DFU admitted to Air Force Medical Center from January 2015 to December 2022. Cox proportional hazards models were used to calculate HR with 95% CI for evaluating the association of PNI with all endpoints and Kaplan–Meier survival curves were generated. Restricted cubic spline (RCS) evaluated non-linear associations, and piecewise regression identified risk thresholds. Causal mediation analysis quantified the mediating effect of eGFR. Results: During a median follow-up of 3.6 years, 378 (30.9%) all-cause deaths, 230 (18.8%) cardiovascular deaths, and 323 (26.4%) MACEs occurred. Multivariable-adjusted Cox proportional hazards models revealed significant inverse associations between PNI and all endpoints. In the fully adjusted model, each 1-unit increase in PNI was associated with a 5% reduction in all-cause mortality risk (HR: 0.95, 95%CI: 0.94–0.97, p < 0.001), a 4% reduction in cardiovascular mortality risk (HR: 0.96, 95%CI: 0.94–0.98, p < 0.001), and a 3% reduction in MACE risk (HR: 0.97, 95%CI: 0.95–0.98, p < 0.001). Quartile analysis revealed progressively decreasing risks across Q2 to Q4 groups versus Q1 (lowest quartile) for all endpoints. Kaplan–Meier survival curves corroborated the Cox regression results. RCS analysis demonstrated significant non-linear relationships between PNI and all endpoints, with exploratory, cohort-specific thresholds identified near 39.29–39.37 (non-linear p < 0.05). Causal mediation analysis revealed that eGFR mediated 11.5 and 11.9% of the effects of PNI on the risks of all-cause mortality and cardiovascular mortality, respectively ( p < 0.05). Conclusion: Prognostic nutritional index is an independent protective factor associated with lower risks of all-cause mortality, cardiovascular mortality, and MACE in patients with DFU. Elevated PNI is associated with significantly reduced risks of all-cause mortality and cardiovascular events, with eGFR partially mediating this association.
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-14
Association Between Neutrophil Percentage-to-Albumin Ratio and All-Cause Mortality and Cardiovascular Events in Patients with Diabetic Foot Ulcers: A Retrospective Cohort Study
Patients with diabetes-related foot ulcers (DFU) face a significantly elevated risk of cardiovascular events and mortality. The neutrophil percentage-to-albumin ratio (NPAR), as a composite inflammatory-nutritional biomarker, has not been thoroughly evaluated for its association with all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE) in the DFU population. To investigate the association between baseline NPAR levels and all-cause mortality, cardiovascular mortality, as well as MACE in patients with DFU. This study enrolled 1175 patients diagnosed with DFU. Based on baseline NPAR quartiles, participants were categorized into four groups: Q1, Q2, Q3, and Q4. Multivariable Cox proportional hazards regression models were employed to calculate hazard ratios (HR) and corresponding 95% confidence intervals (CI). The associations between NPAR and the endpoint events were evaluated using subgroup analyses, Kaplan-Meier curves, and restricted cubic spline models, while the mediating role of eGFR was also examined. During a median follow-up of 3.6 years, a total of 360 all-cause deaths (30.64%), 236 cardiovascular deaths (20.09%), and 323 MACE (27.49%) were recorded. Multivariable-adjusted Cox proportional hazards regression analysis revealed that a per-unit increment in NPAR was associated with a 5% higher hazard of all-cause mortality and MACE, and a 6% higher hazard of cardiovascular mortality. Compared with the Q1 group, the Q4 group of NPAR demonstrated significantly higher risks of all-cause mortality (HR = 1.85), cardiovascular mortality (HR = 1.06), and MACE (HR = 1.05), with all p-values < 0.001. A piecewise regression model revealed that the saturation thresholds for these associations were identified at NPAR values of 20.2, 19.9, and 23.3, respectively. The mediating effects of eGFR accounted for 11.7%, 7.3%, and 8.7% of the total effects on all-cause mortality, cardiovascular mortality, and MACE, respectively. Elevated NPAR levels significantly increase the risk of all-cause mortality, cardiovascular mortality, and MACE in patients with DFU.
- 1 June 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-14
Open AccessAssociation Between Neutrophil Percentage-to-Albumin Ratio and All-Cause Mortality and Cardiovascular Events in Patients with Diabetic Foot Ulcers: A Retrospective Cohort Study
Patients with diabetes-related foot ulcers (DFU) face a significantly elevated risk of cardiovascular events and mortality. The neutrophil percentage-to-albumin ratio (NPAR), as a composite inflammatory-nutritional biomarker, has not been thoroughly evaluated for its association with all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE) in the DFU population. To investigate the association between baseline NPAR levels and all-cause mortality, cardiovascular mortality, as well as MACE in patients with DFU. This study enrolled 1175 patients diagnosed with DFU. Based on baseline NPAR quartiles, participants were categorized into four groups: Q1, Q2, Q3, and Q4. Multivariable Cox proportional hazards regression models were employed to calculate hazard ratios (HR) and corresponding 95% confidence intervals (CI). The associations between NPAR and the endpoint events were evaluated using subgroup analyses, Kaplan-Meier curves, and restricted cubic spline models, while the mediating role of eGFR was also examined. During a median follow-up of 3.6 years, a total of 360 all-cause deaths (30.64%), 236 cardiovascular deaths (20.09%), and 323 MACE (27.49%) were recorded. Multivariable-adjusted Cox proportional hazards regression analysis revealed that a per-unit increment in NPAR was associated with a 5% higher hazard of all-cause mortality and MACE, and a 6% higher hazard of cardiovascular mortality. Compared with the Q1 group, the Q4 group of NPAR demonstrated significantly higher risks of all-cause mortality (HR = 1.85), cardiovascular mortality (HR = 1.06), and MACE (HR = 1.05), with all p-values < 0.001. A piecewise regression model revealed that the saturation thresholds for these associations were identified at NPAR values of 20.2, 19.9, and 23.3, respectively. The mediating effects of eGFR accounted for 11.7%, 7.3%, and 8.7% of the total effects on all-cause mortality, cardiovascular mortality, and MACE, respectively. Elevated NPAR levels significantly increase the risk of all-cause mortality, cardiovascular mortality, and MACE in patients with DFU.
- 1 April 2026
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 35 (Sup4a) , S28-S36
Diagnostic accuracy of C-reactive protein for diabetic foot osteomyelitis: a retrospective study and meta-analysis of composite cut-off values
Objective: To determine the composite cut-off value and diagnostic accuracy of C-reactive protein (CRP) for diabetic foot osteomyelitis (DFO). Method: A retrospective study of patients was combined with a meta-analysis. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Pooled sensitivity, specificity and area under the curve (AUC) were calculated via forest plots and summary receiver operating characteristic curves. A composite cut-off model was developed using R 4.4.3 (R Foundation for Statistical Computing, Austria). Results: The experimental cohort comprised 265 patients (204 with DFO and 61 without). The meta-analysis comprised 12 studies, including a total of 1828 patients. The retrospective cohort demonstrated that CRP achieved an AUC of 0.63 (95% confidence interval (CI): 0.55, 0.71) for diagnosing DFO, with an optimal cut-off value of 9.57mg/l (sensitivity 74%, specificity 53%). Meta-analysis revealed pooled sensitivity of 74% (63–83%) and specificity of 73% (65–79%) (AUC=0.79; 95%CI: 0.75, 0.82). The composite model suggested a CRP cut-off of 15.20mg/l (sensitivity 80%, specificity 53%). Conclusion: In this study, CRP demonstrated moderate diagnostic utility for DFO and could function as a screening adjunct.
- 1 April 2026
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 35 (Sup4a) , S28-S36
Diagnostic accuracy of C-reactive protein for diabetic foot osteomyelitis: a retrospective study and meta-analysis of composite cut-off values
Objective: To determine the composite cut-off value and diagnostic accuracy of C-reactive protein (CRP) for diabetic foot osteomyelitis (DFO). Method: A retrospective study of patients was combined with a meta-analysis. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Pooled sensitivity, specificity and area under the curve (AUC) were calculated via forest plots and summary receiver operating characteristic curves. A composite cut-off model was developed using R 4.4.3 (R Foundation for Statistical Computing, Austria). Results: The experimental cohort comprised 265 patients (204 with DFO and 61 without). The meta-analysis comprised 12 studies, including a total of 1828 patients. The retrospective cohort demonstrated that CRP achieved an AUC of 0.63 (95% confidence interval (CI): 0.55, 0.71) for diagnosing DFO, with an optimal cut-off value of 9.57mg/l (sensitivity 74%, specificity 53%). Meta-analysis revealed pooled sensitivity of 74% (63–83%) and specificity of 73% (65–79%) (AUC=0.79; 95%CI: 0.75, 0.82). The composite model suggested a CRP cut-off of 15.20mg/l (sensitivity 80%, specificity 53%). Conclusion: In this study, CRP demonstrated moderate diagnostic utility for DFO and could function as a screening adjunct.
- Open Access
- 25 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1660465
Diagnostic value and integrated threshold of ESR for diabetic foot osteomyelitis: a systemic review and meta-analysis
Background: Diabetic foot osteomyelitis (DFO) is a severe complication of diabetic foot infections (DFI). Early and accurate diagnosis is crucial for improving patient outcomes. The erythrocyte sedimentation rate (ESR), a commonly used inflammatory marker, has been controversial regarding its diagnostic value and optimal cutoff values in DFO.Objective: This study aims to conduct a systematic review and meta-analysis to comprehensively evaluate the diagnostic efficacy of ESR for DFO and to determine an optimal pooled cutoff value for the marker.Methods: A systematic search of PubMed, EMBASE, Cochrane Library, OVID, and the Wanfang database was conducted for literature related to ESR in the diagnosis of DFO, with the search period extending through March 2025. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was applied for quality evaluation of the included studies. Statistical analyses were performed using Stata 18.0 to generate hierarchical summary receiver operating characteristic (HSROC) curves and forest plots for assessing the diagnostic performance of ESR in DFO. To determine the optimal composite cutoff value of ESR for diagnosing DFO, a different random intercepts and common random slope (DICS) model was implemented using R4.5.0. Subsequently, a Generalized Linear Mixed Model (GLMM) was constructed to predict the corresponding sensitivity and specificity at the ESR threshold of 70 mm/h.Results: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 12 studies with a total of 1,674 subjects were included. The HSROC model revealed that the area under the curve (AUC) for ESR in diagnosing DFO was 0.71, with sensitivity and specificity values of 0.76 and 0.73, respectively. The DICS model identified an optimal pooled cutoff value for ESR at 51.6 mm/h, with corresponding sensitivity and specificity values of 0.80 and 0.67, respectively. Using the GLM model, an ESR cutoff of 70 mm/h yielded sensitivity and specificity of 0.61 and 0.83, respectively.Conclusion: ESR demonstrates moderate diagnostic efficacy in the identification of DFO. Based on our findings, we recommend the optimal pooled cutoff value for ESR is 51.6 mm/h, as a preliminary screening tool in the diagnostic workup of DFO.
- 25 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1660465
Open AccessDiagnostic value and integrated threshold of ESR for diabetic foot osteomyelitis: a systemic review and meta-analysis
Background: Diabetic foot osteomyelitis (DFO) is a severe complication of diabetic foot infections (DFI). Early and accurate diagnosis is crucial for improving patient outcomes. The erythrocyte sedimentation rate (ESR), a commonly used inflammatory marker, has been controversial regarding its diagnostic value and optimal cutoff values in DFO.Objective: This study aims to conduct a systematic review and meta-analysis to comprehensively evaluate the diagnostic efficacy of ESR for DFO and to determine an optimal pooled cutoff value for the marker.Methods: A systematic search of PubMed, EMBASE, Cochrane Library, OVID, and the Wanfang database was conducted for literature related to ESR in the diagnosis of DFO, with the search period extending through March 2025. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was applied for quality evaluation of the included studies. Statistical analyses were performed using Stata 18.0 to generate hierarchical summary receiver operating characteristic (HSROC) curves and forest plots for assessing the diagnostic performance of ESR in DFO. To determine the optimal composite cutoff value of ESR for diagnosing DFO, a different random intercepts and common random slope (DICS) model was implemented using R4.5.0. Subsequently, a Generalized Linear Mixed Model (GLMM) was constructed to predict the corresponding sensitivity and specificity at the ESR threshold of 70 mm/h.Results: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 12 studies with a total of 1,674 subjects were included. The HSROC model revealed that the area under the curve (AUC) for ESR in diagnosing DFO was 0.71, with sensitivity and specificity values of 0.76 and 0.73, respectively. The DICS model identified an optimal pooled cutoff value for ESR at 51.6 mm/h, with corresponding sensitivity and specificity values of 0.80 and 0.67, respectively. Using the GLM model, an ESR cutoff of 70 mm/h yielded sensitivity and specificity of 0.61 and 0.83, respectively.Conclusion: ESR demonstrates moderate diagnostic efficacy in the identification of DFO. Based on our findings, we recommend the optimal pooled cutoff value for ESR is 51.6 mm/h, as a preliminary screening tool in the diagnostic workup of DFO.
- Open Access
- 31 January 2025
- Published by Frontiers Media SA in Frontiers in Artificial Intelligence
- Vol. 8, 1455341
Artificial intelligence applied to diabetes complications: a bibliometric analysis
Background and aims: Artificial intelligence (AI)-driven medical assistive technology has been widely used in the diagnosis, treatment and prognosis of diabetes complications. Here we conduct a bibliometric analysis of scientific articles in the field of AI in diabetes complications to explore current research trends and cutting-edge hotspots.Methodology: On April 20, 2024, we collected and screened relevant articles published from 1988 to 2024 from PubMed. Based on bibliometric tools such as CiteSpace, Vosviewer and bibliometix, we construct knowledge maps to visualize literature information, including annual scientific production, authors, countries, institutions, journals, keywords and research hotspots.Results: A total of 935 articles meeting the criteria were collected and analyzed. The number of annual publications showed an upward trend. Raman, Rajiv published the most articles, and Webster, Dale R had the highest collaboration frequency. The United States, China, and India were the most productive countries. Scientific Reports was the journal with the most publications. The three most frequent diabetes complications were diabetic retinopathy, diabetic nephropathy, and diabetic foot. Machine learning, diabetic retinopathy, screening, deep learning, and diabetic foot are still being researched in 2024.Conclusion: Global AI research on diabetes complications is expected to increase further. The investigation of AI in diabetic retinopathy and diabetic foot will be the focus of research in the future.
- 31 January 2025
- Published by Frontiers Media SA in Frontiers in Artificial Intelligence
- Vol. 8, 1455341
Open AccessArtificial intelligence applied to diabetes complications: a bibliometric analysis
Background and aims: Artificial intelligence (AI)-driven medical assistive technology has been widely used in the diagnosis, treatment and prognosis of diabetes complications. Here we conduct a bibliometric analysis of scientific articles in the field of AI in diabetes complications to explore current research trends and cutting-edge hotspots.Methodology: On April 20, 2024, we collected and screened relevant articles published from 1988 to 2024 from PubMed. Based on bibliometric tools such as CiteSpace, Vosviewer and bibliometix, we construct knowledge maps to visualize literature information, including annual scientific production, authors, countries, institutions, journals, keywords and research hotspots.Results: A total of 935 articles meeting the criteria were collected and analyzed. The number of annual publications showed an upward trend. Raman, Rajiv published the most articles, and Webster, Dale R had the highest collaboration frequency. The United States, China, and India were the most productive countries. Scientific Reports was the journal with the most publications. The three most frequent diabetes complications were diabetic retinopathy, diabetic nephropathy, and diabetic foot. Machine learning, diabetic retinopathy, screening, deep learning, and diabetic foot are still being researched in 2024.Conclusion: Global AI research on diabetes complications is expected to increase further. The investigation of AI in diabetic retinopathy and diabetic foot will be the focus of research in the future.
- Open Access
- 10 June 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1371527
Secondary adrenocortical insufficiency after treatment with retifanlimab: a case report
With advancements in medical oncology, immune checkpoint inhibitors (ICIs) have become the first-line treatment for many malignancies. ICIs play a significant role in improving cancer prognosis, but a series of immune-related adverse events (irAEs), including immune-related endocrine events (irEEs), caused by ICIs have also aroused concerns. Rapid clinical identification of irAEs caused by ICIs is particularly important. We describe a case of secondary adrenocortical insufficiency (AI) after PD-1 treatment in a postoperative patient with endometrial cancer. A 73-year-old female patient developed anorexia, nausea, vomiting, malaise, electrolyte disturbances, ineffective symptomatic treatment, and decreased serum adrenocorticotropin and cortisol levels six months after retifanlimab treatment. The vomiting resolved, and the electrolyte levels were corrected after 3 days of treatment with glucocorticoids (hydrocortisone, intravenous, 200 mg/day). When patients present with gastrointestinal symptoms, such as poor appetite and nausea, not only symptomatic treatment but also a search for the etiology behind the symptoms is needed, especially in immunotherapy patients who should undergo a thorough evaluation of the endocrine system and be alert for adrenocortical insufficiency.
- 10 June 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1371527
Open AccessSecondary adrenocortical insufficiency after treatment with retifanlimab: a case report
With advancements in medical oncology, immune checkpoint inhibitors (ICIs) have become the first-line treatment for many malignancies. ICIs play a significant role in improving cancer prognosis, but a series of immune-related adverse events (irAEs), including immune-related endocrine events (irEEs), caused by ICIs have also aroused concerns. Rapid clinical identification of irAEs caused by ICIs is particularly important. We describe a case of secondary adrenocortical insufficiency (AI) after PD-1 treatment in a postoperative patient with endometrial cancer. A 73-year-old female patient developed anorexia, nausea, vomiting, malaise, electrolyte disturbances, ineffective symptomatic treatment, and decreased serum adrenocorticotropin and cortisol levels six months after retifanlimab treatment. The vomiting resolved, and the electrolyte levels were corrected after 3 days of treatment with glucocorticoids (hydrocortisone, intravenous, 200 mg/day). When patients present with gastrointestinal symptoms, such as poor appetite and nausea, not only symptomatic treatment but also a search for the etiology behind the symptoms is needed, especially in immunotherapy patients who should undergo a thorough evaluation of the endocrine system and be alert for adrenocortical insufficiency.
- Open Access
- 26 January 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1336382
Case report: POEMS syndrome masquerades as diabetic foot
We present the case of a 54-year-old woman with reasonable blood sugar control who presented with a diabetic foot combined with severe peripheral neuropathy and vascular disease. Lower limb muscle weakness, muscle atrophy, skin pigmentation, and emaciation were also observed. Although her muscle strength improved after glucocorticoid treatment, it remained challenging to account for the other symptoms in this particular patient with chronic inflammatory demyelinating polyneuropathy. Plump liver and spleen, hidden bone lesions combined with seemingly unexplained cerebral infarction, and serous effusion led us to suspect polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. The abnormal proliferation of monoclonal plasma cells and a significant increase in vascular endothelial growth factor (VEGF) levels confirmed the diagnosis of POEMS syndrome. After 1 month of treatment with lenalidomide and dexamethasone, the diabetic foot ulcers healed, and the symptoms of myasthenia and fatigue improved. Diabetic feet may represent only the tip of the iceberg of an underlying POEMS syndrome. Our report aimed to increase awareness of this rare yet significant situation, advocating for the prompt identification and treatment of POEMS syndrome.
- 26 January 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1336382
Open AccessCase report: POEMS syndrome masquerades as diabetic foot
We present the case of a 54-year-old woman with reasonable blood sugar control who presented with a diabetic foot combined with severe peripheral neuropathy and vascular disease. Lower limb muscle weakness, muscle atrophy, skin pigmentation, and emaciation were also observed. Although her muscle strength improved after glucocorticoid treatment, it remained challenging to account for the other symptoms in this particular patient with chronic inflammatory demyelinating polyneuropathy. Plump liver and spleen, hidden bone lesions combined with seemingly unexplained cerebral infarction, and serous effusion led us to suspect polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. The abnormal proliferation of monoclonal plasma cells and a significant increase in vascular endothelial growth factor (VEGF) levels confirmed the diagnosis of POEMS syndrome. After 1 month of treatment with lenalidomide and dexamethasone, the diabetic foot ulcers healed, and the symptoms of myasthenia and fatigue improved. Diabetic feet may represent only the tip of the iceberg of an underlying POEMS syndrome. Our report aimed to increase awareness of this rare yet significant situation, advocating for the prompt identification and treatment of POEMS syndrome.
- Open Access
- 4 January 2024
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 20 (1) , 2297455
Hypophysitis after COVID-19 vaccination in a patient with Rathke’s cleft cyst: A case report
With the widespread vaccination of COVID-19 vaccine, a few cases have been reported that COVID-19 vaccine may cause endocrine disorders. A 59-y-old man presented with a loss of appetite after the first COVID-19 vaccination, which resolved spontaneously after 3 d. After the second COVID-19 vaccination, the symptoms including the loss of appetite, nausea, and vomiting reappeared and worsened along with loss of vision. He was found to have severe hyponatremia, and further investigations revealed secondary adrenal insufficiency, secondary hypothyroidism and Rathke's cleft cyst. The patient responded well to glucocorticoid and levothyroxine supplementation, and at 1-y follow-up the patient developed hypogonadism. We hypothesize that hypophysitis is probably induced by COVID-19 vaccine and report the rare but serious adverse reactions for early recognition and intervention.
- 4 January 2024
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 20 (1) , 2297455
Open AccessHypophysitis after COVID-19 vaccination in a patient with Rathke’s cleft cyst: A case report
With the widespread vaccination of COVID-19 vaccine, a few cases have been reported that COVID-19 vaccine may cause endocrine disorders. A 59-y-old man presented with a loss of appetite after the first COVID-19 vaccination, which resolved spontaneously after 3 d. After the second COVID-19 vaccination, the symptoms including the loss of appetite, nausea, and vomiting reappeared and worsened along with loss of vision. He was found to have severe hyponatremia, and further investigations revealed secondary adrenal insufficiency, secondary hypothyroidism and Rathke's cleft cyst. The patient responded well to glucocorticoid and levothyroxine supplementation, and at 1-y follow-up the patient developed hypogonadism. We hypothesize that hypophysitis is probably induced by COVID-19 vaccine and report the rare but serious adverse reactions for early recognition and intervention.
- Open Access
- 2 August 2022
- Published by Taylor & Francis in Medical Teacher
- Vol. 44 (12) , 1413-1419
Understanding online self-directed learning using point of care information systems (POCIS): A plot study using a capability approach perspective
Understanding self-directed learning (SDL) when using point of care information systems (POCIS) can inform educational providers of the usefulness of the system for continuing medical education (CM...
- 2 August 2022
- Published by Taylor & Francis in Medical Teacher
- Vol. 44 (12) , 1413-1419
Open AccessUnderstanding online self-directed learning using point of care information systems (POCIS): A plot study using a capability approach perspective
Understanding self-directed learning (SDL) when using point of care information systems (POCIS) can inform educational providers of the usefulness of the system for continuing medical education (CM...